Topical use of tranexamic acid in open heart surgery.

OBJECTIVE To determine the efficacy of topical pouring of tranexamic acid in reducing post-operative mediastinal bleeding, requirement for blood products and the rate of re-exploration for re-securing haemostasis or relief of pericardial tamponade after open heart surgery. METHODS The prospective, randomised, placebo-controlled, double-blind comparative study was conducted from March 2013 to September 2015 at Rehmatul-lil-Alameen Institute of Cardiology, Punjab Employees Social Security Institution, Lahore, and comprised patients scheduled for primary isolated elective or urgent open heart surgery. The subjects were divided into two equal groups. The hetranexamic acid group received cardiac bath with 2gm of tranexamic acid diluted in 50mlof normal saline, while the placebo group received cardiac bath without tranexamic acid. Before the closure of sternum, the solution was poured into pericardial cavity as cardiac bath while the chest tubes were temporarily clamped. Data was entered into a pre-designed proforma. RESULTS Of the 100 subjects, there were 50(50%) in each of the two groups. There was no difference in surgical characteristics and perioperative complications in the groups (p>0.05). After 48 post-operative hours, total blood loss was significantly less in the tranexamic acid group compared to the placebo group (p<0.05). Significantly less number of blood pints were transfused in the acid group than the placebo group (p<0.05). No patient in the acid group was re-explored for excessive bleeding compared to 4(8%) in the placebo group. CONCLUSIONS There was significant reduction in post-operative blood drainage, need of blood products and rate of re-exploration after topical use of tranexamic acid in open heart surgery.

[1]  M. Verstraete,et al.  Clinical Application of Inhibitors of Fibrinolysis , 1985, Drugs.

[2]  H. Fawzy,et al.  Can local application of Tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial , 2009, Journal of cardiothoracic surgery.

[3]  G. Gravlee.  A Comparison of Aprotinin and Lysine Analogues in High-Risk Cardiac Surgery , 2009 .

[4]  S. Hosseini,et al.  ROLE OF EPSILON AMINOCAPROIC ACID & TRANEXAMIC ACID, VS PLACEBO IN REDUCTION OF MEDIASTINAL BLEEDING FOLLOWING OPEN HEART SURGERY , 2009 .

[5]  R. Martineau,et al.  A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. , 2008, The New England journal of medicine.

[6]  B. Biočina,et al.  Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[7]  K. M. Abdullah,et al.  Effect of topical tranexamic acid in open heart surgery , 2006, European journal of anaesthesiology.

[8]  R. Kalil,et al.  A randomized, double-blind, and placebo-controlled study with tranexamic acid of bleeding and fibrinolytic activity after primary coronary artery bypass grafting. , 2006, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[9]  Z. Straka,et al.  Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo). , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[10]  A. Yasim,et al.  [Effects of topical applications of aprotinin and tranexamic acid on blood loss after open heart surgery]. , 2005, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology.

[11]  P. Kalmar,et al.  Activation of fibrinolysis in the pericardial cavity after cardiopulmonary bypass , 2004, Thrombosis and Haemostasis.

[12]  O. Alfieri,et al.  Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions. , 2000, The Journal of thoracic and cardiovascular surgery.

[13]  F. Cavaliere,et al.  Topical use of tranexamic acid in coronary artery bypass operations: a double-blind, prospective, randomized, placebo-controlled study. , 2000, The Journal of thoracic and cardiovascular surgery.

[14]  K. Goa,et al.  Tranexamic acid: a review of its use in surgery and other indications. , 1999, Drugs.

[15]  P. Mongan,et al.  Tranexamic Acid and Aprotinin Reduce Postoperative Bleeding and Transfusions During Primary Coronary Revascularization , 1998, Anesthesia and analgesia.

[16]  S. Westaby,et al.  Topical aprotinin in cardiac operations. , 1994, The Annals of thoracic surgery.

[17]  C. Tatooles,et al.  Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency. A multicenter, randomized, double-blind, placebo-controlled study. , 1994, The Journal of thoracic and cardiovascular surgery.

[18]  U. Demirkılıç,et al.  Topical use of aprotinin in open heart operations. , 1993, The Annals of thoracic surgery.

[19]  M. Abdelnoor,et al.  Tranexamic acid (Cyklokapron) is not necessary to reduce blood loss after coronary artery bypass operations. , 1993, The Journal of thoracic and cardiovascular surgery.

[20]  J. Desroches,et al.  Natural and synthetic antifibrinolytics in cardiac surgery , 1992, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[21]  M. Blombäck,et al.  Hemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery. , 1989, The New England journal of medicine.

[22]  A. Valsecchi.  [Further notes on the topical use of tranexamic acid in the treatment of gynecological hemorrhage]. , 1980, Minerva ginecologica.